INDOUS

Indo Us Biotech Limited

Indo Us Biotech Limited (INDOUS) financial statements and selected valuation metrics through 30 June 2026.

Fast Moving Consumer Goods›Fast Moving Consumer Goods›Agricultural Food & other Products›Other Agricultural Products

indousagriseeds.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹71.95
Market cap
145 Cr
Stock P/E
12.6
P/B
1.56
Dividend yield
0.3%
ROE (FY22)
13.1%
ROCE (FY22)
16.8%
Operating margin (FY22)
12.6%
Debt / equity (FY22)
0.00
OCF / EBITDA (FY26)
-94.6%
OCF / EBITDA (3Y)
-55.1%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Indo US Biotech grows, processes and trades seeds in Gujarat, selling to farmers and retail customers.

Company snapshot

19thBy market cap

Ranked among 23 companies in Other Agricultural Products.

What we see

Positives
  • ✓Revenue grew 25% in the latest year — strong top-line momentum.
Concerns
  • ✗Over the last three years operations used more cash than they brought in, despite an operating profit — the business is not yet turning its profit into cash.
1 more signal from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 20231Dec 2023Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales19 Cr16 Cr22 Cr25 Cr22 Cr24 Cr33 Cr31 Cr31 Cr23 Cr26 Cr33 Cr
Operating expenses (approx.)16 Cr10 Cr18 Cr21 Cr17 Cr18 Cr29 Cr25 Cr27 Cr19 Cr23 Cr29 Cr
EBITDA3 Cr6 Cr4 Cr4 Cr5 Cr6 Cr5 Cr5 Cr4 Cr4 Cr3 Cr4 Cr
OPM %15.6%39.5%19.2%14.9%23.1%23.5%13.7%17.8%13.5%18.2%12.4%12.0%
Other income0.03 Cr0.0030 Cr0.08 Cr0.03 Cr0.02 Cr0.02 Cr0.12 Cr0.0015 Cr0.03 Cr0.0050 Cr0.02 Cr0.12 Cr
Interest0.37 Cr0.04 Cr0.37 Cr0.33 Cr0.52 Cr0.38 Cr0.26 Cr0.45 Cr0.42 Cr0.77 Cr0.60 Cr0.74 Cr
Depreciation0.20 Cr4 Cr0.19 Cr0.20 Cr0.18 Cr0.16 Cr0.56 Cr0.20 Cr0.21 Cr0.22 Cr0.27 Cr0.27 Cr
Profit before tax2 Cr2 Cr4 Cr3 Cr4 Cr5 Cr4 Cr5 Cr4 Cr3 Cr2 Cr3 Cr
Tax %3.0%—1.8%0.6%1.9%-0.7%5.0%2.4%3.0%5.3%17.1%1.3%
Net profit2 Cr2 Cr4 Cr3 Cr4 Cr5 Cr4 Cr5 Cr3 Cr3 Cr2 Cr3 Cr
EPS (₹)₹2.37—₹1.84₹1.58₹2.16₹2.52₹1.86₹2.35₹1.72₹1.49₹0.98₹1.51
  1. 1Sept 2023: Derived from year-to-date: the half-year to 30 Sep 2023 less the quarter to 30 Jun 2023; the filing gives no figures for this quarter alone

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2018Mar 2019Mar 2020Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales30 Cr35 Cr40 Cr50 Cr62 Cr73 Cr104 Cr110 CrSign in free for the trailing twelve months
Operating expenses (approx.)27 Cr32 Cr36 Cr43 Cr52 Cr62 Cr85 Cr93 CrSign in free for the trailing twelve months
EBITDA3 Cr3 Cr4 Cr7 Cr9 Cr11 Cr19 Cr17 CrSign in free for the trailing twelve months
OPM %9.0%9.7%10.0%13.8%15.2%14.8%18.2%15.4%Sign in free for the trailing twelve months
Other income0.22 Cr0.03 Cr0.0079 Cr0.18 Cr0.02 Cr0.32 Cr0.18 Cr0.05 CrSign in free for the trailing twelve months
Interest0.69 Cr0.40 Cr0.88 Cr1 Cr1 Cr2 Cr1 Cr2 CrSign in free for the trailing twelve months
Depreciation0.15 Cr0.25 Cr0.23 Cr0.44 Cr0.83 Cr0.80 Cr1 Cr0.90 CrSign in free for the trailing twelve months
Profit before tax2 Cr3 Cr3 Cr5 Cr7 Cr9 Cr17 Cr14 CrSign in free for the trailing twelve months
Tax %29.0%25.7%10.6%4.6%2.0%6.3%1.6%5.7%Sign in free for the trailing twelve months
Net profit1 Cr2 Cr3 Cr5 Cr7 Cr8 Cr16 Cr13 CrSign in free for the trailing twelve months
EPS (₹)₹4.23₹4.45₹4.18₹8.59₹7.51₹4.11₹8.12₹6.54Sign in free for the trailing twelve months
Dividend payout %———-2.9%0.0%0.0%3.1%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2018Mar 2019Mar 2020Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital3 Cr5 Cr6 Cr9 Cr10 Cr20 Cr20 Cr20 Cr
Reserves2 Cr9 Cr10 Cr30 Cr44 Cr43 Cr58 Cr72 Cr
Borrowings——8 Cr13 Cr——15 Cr37 Cr
Other liabilities12 Cr10 Cr10 Cr4 Cr15 Cr22 Cr4 Cr4 Cr
Total liabilities17 Cr24 Cr35 Cr56 Cr69 Cr84 Cr98 Cr133 Cr
Fixed assets (net)2 Cr3 Cr1 Cr6 Cr9 Cr10 Cr10 Cr11 Cr
CWIP——1 Cr2 Cr———0.50 Cr
Investments0 Cr0 Cr0 Cr0.0099 Cr0 Cr0 Cr0 Cr0 Cr
Loans & advances——2 Cr3 Cr——0 Cr0 Cr
Inventories6 Cr11 Cr9 Cr23 Cr27 Cr52 Cr71 Cr100 Cr
Trade receivables9 Cr9 Cr21 Cr21 Cr25 Cr19 Cr15 Cr14 Cr
Cash & bank0.03 Cr0.06 Cr0.20 Cr0.05 Cr0.19 Cr1 Cr0.25 Cr6 Cr
Other assets0.43 Cr1 Cr0.16 Cr0.94 Cr9 Cr2 Cr2 Cr2 Cr
Total assets17 Cr24 Cr35 Cr56 Cr69 Cr84 Cr98 Cr133 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2018Mar 2019Mar 2020Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity—-3 Cr-0.79 Cr-5 Cr0.53 Cr-8 Cr-1 Cr-16 Cr
Cash from investing—-3 Cr-0.59 Cr5 Cr7 Cr9 Cr-0.79 Cr3 Cr
Cash from financing—6 Cr1 Cr5 Cr7 Cr4 Cr-1 Cr24 Cr
Net cash flow—0.01 Cr0.12 Cr5 Cr14 Cr6 Cr-4 Cr12 Cr
Free cash flow (OCF − Capex)—-4 Cr-1 Cr-5 Cr0.53 Cr-8 Cr-1 Cr-16 Cr

Ratios

MetricMar 2021Mar 2022
ROCE %16.0%16.8%
ROE %23.0%13.1%
Debtor days224149
Inventory days1723905
Days payable130—
Cash conversion cycle2674055
OCF / EBITDA %8.2%40.0%
Debt / equity0.500.00
Current ratio2.103.81
Net debt / EBITDA1.96-0.0073